By Ajay K. Nooka, MD, et al. ABSTRACT PURPOSE Vaccine-induced neutralizing antibodies (nAbs) play a critical role in protection from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased risk of COVID-19–related mortality and exhibit...
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
read more